Home
overview

SMi is proud to present their 4th annual KOL Europe Conference...

KOL Management and MSL Best Practice in Europe 2012

2nd & 3rd July 2012, Basel, Switzerland

About the Conference: SMi's 4th Annual European KOL and MSL conference will provide attendees with an in depth view into the most effective methods and strategies for pharma to use when recruiting and managing KOLs for dispersing medical or scientific information to stakeholders and the public

Identifying and building relationships with key opinion leaders is an essential part of the development process and it is important that the challenges in this field are addressed and solutions found. The event will explore KOL Communication strategies, KOLs in Market Access, Health Economics, MSL Evaluations, and Relationships with Patients and Government Bodies

This event will be focused on case-studies to add context to the presentations and will act as the perfect platform for discussion and problem-solving debate. Allowing for plenty of discussion within the agenda this conference is unique in providing an ideal platform to obtain the building blocks needed for successful KOL interactions and MSL programmes, whilst offering networking opportunities throughout the event.

Testimonials from delegates of our 2011 event:
"Excellent speaker and content" Boehringer-Ingelheim
"Good & new information, well presented & discussed" UCB
"Really good presenter & relevant information" ABPI
 

 

 

 


Interested in speaking at the conference; Do you know of anyone who may be interested in speaking; We are always on the look-out for new speakers for our upcoming conferences; Let us know - contact the the Conference Producer

For sponsorship and exhibiting opportunities, contact our Sponsorship Department

Key Benefits of Attending:

Hear from some of the leading experts in identifying, approaching and managing KOLs and KOL programmes

Learn the how to improve and sustain relationships with Patients and Government Bodies

Discover the best ways to manage the your medical and scientific advice output in the long term for the benefit of your brand

Network with MSLs, KOLs, industry leaders and medical communication agencies

 

Who should attend this event?

Chief Executives, Vice Presidents, Heads, Directors, and Project Leaders of

  • Medical Science Liaisons, MSLs
  • Medical Affairs, Scientific Affairs
  • Medical Advisors, Scientific Advisors
  • KOL Development, KOL Relationships
  • Key Opinion Management
  • External Speaker Faculty Management
  • Medical Communications
  • Clinical Outcomes
  • Scientific Affairs
  • Medical Education
  • External Stakeholder Management/Liaison
  • Programme/Product/Brand Management
  • Marketing
  • Professional Education

Delegates at our KOL event in Munich in June 2010 came from across the world... Join the wide range of high level delegates again at our event in 2011..

Graph of delegate countries

  

Previous attendees and participants have come from organizations including:

 

  • Shire
  • Pfizer
  • Grunenthal 
  • Boehringer Ingelheim
  •  Nycomed
  • Innogenetics
  • European Parkinsons Disease Association
  • Merck
  • Leo Pharma 
  • Eli Lilly
  • AstraZeneca
  • Association of the British Pharmaceutical Industry
  • Genzyme
  • Kings College, London
  • Bristol-Myers Squibb
  • UCB Gmbh
  • Novartis
  • Bayer Schering Pharma
  • MedImmune
  • Amgen
  • Harvard Medical School 
  • GSK
  • Sanofi-Aventis 
  • Abbott
  • Napp Pharmacueticals
  • Mederi
  • Caudex Medical
  • Tachris AG
  • Celgene International
  • Biogen Idec International
  • University College London
  • British Medical Journal
  • Norgine 
  • Vifor Pharma

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

9:10 Ensuring regulatory compliance when approaching the outside world

Mario Monella

Mario Monella, Director of Medical Affairs, Astellas Pharma Europe Ltd

  • Industry trends in MSL compliance
  • Common issues and uncertainties related to privacy
  • Structure and strategies for ensuring global compliance
  • Following regulatory guidelines and documentation
  • 9:50 Cross-Regional KOL management

    Eddy Wu

    Eddy Wu, Medical Director, Novartis Pharmaceuticals

  • Maximize invested resources
  • Define “good” standard, and make it “better”
  • Enhance country-country cooperation
  • 10:30 Morning Coffee

    11:00 MSL in Orphan Disease: Hand-in-hand with a targeted sales force

    Andreas Brecht

    Andreas Brecht, Medical Scientific Liaison, Actelion Pharmaceuticals

    11:40 New developments and relationships in continuing medical education (CME)

    Tom Pulles

    Tom Pulles, International Medical Director, Shire AG

  • What are the current challenges and changes in the CME landscape?
  • Is it possible to bring multiple stakeholder groups together to develop education programmes in Europe?
  • What is the role of the medical society in (European) CME?
  • Can CME actually have an effect on clinical practice?
  • What are the concerns about commercial organisations being involved in (accredited) CME meetings?
  • 12:20 Networking Lunch

    13:50 Developing MSL best practice strategies

    David Gillen

    David Gillen, Medical Director , Celgene Europe Limited

    14:30 Panel Discussion - How important are KOLs to the Pharma industry and how best can we manage them?

    15:20 Afternoon Tea

    15:50 KOL management in developing countries

    Stephen Toovey

    Stephen Toovey, Medical Consultant, Virology, Roche Pharmaceuticals

  • Policital and security issues
  • The importance of securing data transfer
  • Embracing new technology in your communication strategy
  • Making the most of the KOL in this situation
  • 16:30 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Dirk Roosen

    Dirk Roosen, Managing Director, R&S Management Consultancy

    9:10 The role of patient and physician associations

    Susanna Palkonen

    Susanna Palkonen, Executive Officer, EFA

  • New legislation and how this will effect KOL relations
  • Physicians backing away from industry relations
  • Will Patient Opinion Leaders (POLs) replace KOLs
  • How to get these groups on board
  • How do patient organisations feel about engaging
  • 9:40 Getting the most from Patient Association partnerships

    Keith Allan

    Keith Allan, Director, Global Advocacy, Novartis Pharma Ag

    • The potential influence of patient advocates
    • Understanding the principles of partnership
    • What patient associations want from industry
    • Rules of engagement

    10:10 Q & A: Opportunities and Challenges of Patient Association Relations

    Keith Allan

    Keith Allan, Director, Global Advocacy, Novartis Pharma Ag

    Susanna Palkonen

    Susanna Palkonen, Executive Officer, EFA

    10:30 Morning Coffee

    11:00 Types of initiatives involving both KOLs and Patient Groups

    Nick Hicks

    Nick Hicks, Founder, Commutateur

  • What dictates a successful outcome 
  • What Patient Groups are saying
  • EULAR recommendations on working with Patient Groups in research
  • Best practice case histories
  • 11:40 Building and sustaining industry-academia relationships

    Thomas D. Szucs

    Thomas D. Szucs, Chairman, European Centre of Pharmaceutical Medicine (ECPM)

  • Identifying the correct partner - what to look for and where to find it?
  • Utilising these relationships to their full potential
  • The importance of maintaining long term relationships - how can we do this?
  • How and when should these partnerships end?
  • 12:20 Networking Lunch

    13:50 Improving effectiveness of MSLs

    Sven Erickson

    Sven Erickson, Medical Science Liaison - Opthalmics, Novartis Sverige AB

  • Performance metrics and management
  • How can communication and transparency improve MSL activity
  • Methods to increase scientific information exchange
  • Overcoming obstacles in information sharing
  • 14:30 Evaluating MSL value

    Dirk Roosen

    Dirk Roosen, Managing Director, R&S Management Consultancy

  • MSL activity
  • Allocation of resources to MSL activities
  • Different activty ratios for organisations
  • Challenges for MSL managers
  • 15:10 Afternoon Tea

    15:40 KOLs, physicians and new media

    Thierry Weber

    Thierry Weber, MD, Partner, Vivactis

  • Update on E-medical education
  • Integration of KOLs in e-Learning and e-Meded - spreading the word to peers and physicians
  • E-tools and science: update on online registries and studies
  • E-marketing benefits of e-communication in the healthcare sector
  • Help your KOLs gain visibility by capitalizing on new media (web and mobile media)
  •  

    16:20 The internet, social media and mobile

    Daniel Ghinn

    Daniel Ghinn, CEO, Creation Healthcare

  • How emerging channels are changing healthcare engagement
  • Focus on how pharma's stakeholder communicate
  • Influencing other KOLs using emerging channels
  • What does this mean for the pharma industry?
  • 17:00 Chairman’s Closing Remarks and Close of Day Two

    Dirk Roosen

    Dirk Roosen, Managing Director, R&S Management Consultancy

    +

    VENUE

    Radisson Blu Hotel Basel

    Steinentorstrasse 25, Basel, Switzerland

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Radisson Blu Hotel Basel

    Steinentorstrasse 25
    Basel CH-4001
    Switzerland

    Radisson Blu Hotel Basel

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.